The company depends on third-party manufacturers for its product candidates and may need to obtain licenses to engage additional manufacturers. Transitioning to new manufacturers requires verification that they meet quality standards and regulatory requirements and produce equivalent products. Delays in this verification process can adversely affect development timelines and budgets. Noncompliance with manufacturing requirements or current Good Manufacturing Practice (cGMP) standards may result in failure to meet product specifications, delays in clinical trials and regulatory approvals, inability to commercialize products on schedule, loss of collaborators, regulatory inspections, product recalls, inability to satisfy commercial demand, and reduced profit margins. Additionally, changes in manufacturing methods or formulation during development may increase costs, delay trials, impact product performance, and jeopardize commercialization and revenue generation.
Immuneering's Comment on Supply Chain
The company depends on third-party manufacturers for its product candidates and may need to obtain licenses to engage additional manufacturers. Transitioning to new manufacturers requires verification that they meet quality standards and regulatory requirements and produce equivalent products. Delays in this verification process can adversely affect development timelines and budgets. Noncompliance with manufacturing requirements or current Good Manufacturing Practice (cGMP) standards may result in failure to meet product specifications, delays in clinical trials and regulatory approvals, inability to commercialize products on schedule, loss of collaborators, regulatory inspections, product recalls, inability to satisfy commercial demand, and reduced profit margins. Additionally, changes in manufacturing methods or formulation during development may increase costs, delay trials, impact product performance, and jeopardize commercialization and revenue generation.
Sources:
Immuneering Corporation's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Immuneering Corporation’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
